EUVIMEDEUVIMED entdecken
Crossref

Medicinal cannabis delivery systems: A perspective

Diego E. Boldrini, Olivia V. López

Innovative Medicines & Omics · 2024

DOI: 10.36922/imo.4448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innovative Medicines & Omics, 2024. Verfasst von Diego E. Boldrini und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, cannabis derivatives have been proposed for the treatment of various medical conditions, including pain, inflammation, epilepsy, sleep disorders, multiple sclerosis, anorexia, schizophrenia, neurodegenerative diseases, nausea, and cancer. While the benefits of cannabis derivatives, primarily cannabinoids, have been demonstrated and continue to be studied, their use presents various challenges associated with their low water solubility, rapid metabolism, erratic and poor bioavailability, and erratic pharmacokinetics, which directly affect their efficacy. In this context, a great deal of research is being carried out to overcome these drawbacks by designing delivery systems capable of improving solubility/bioavailability, potency, and efficacy, while addressing the purity and quality issues required by the pharmaceutical industry. This article aims to critically review the major trends and challenges in designing controlled-release cannabinoid delivery systems and their potential application in the pharmaceutical industry.

Zitieren

APA

Boldrini, D. E., & López, O. V. (2024). Medicinal cannabis delivery systems: A perspective. Innovative Medicines & Omics. https://doi.org/10.36922/imo.4448

Vancouver

Boldrini DE, López OV. Medicinal cannabis delivery systems: A perspective. Innovative Medicines & Omics. 2024. doi:10.36922/imo.4448

BibTeX
@article{Boldrini2024,
  author = {Boldrini, Diego E. and López, Olivia V.},
  title = {Medicinal cannabis delivery systems: A perspective},
  journal = {Innovative Medicines & Omics},
  year = {2024},
  doi = {10.36922/imo.4448}
}
Kostenlos starten →